PriceTargets.com logo

Tenon Medical - TNON Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $3.00
  • Forecasted Upside: -15.73%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.56 As of 10/11/2024 01:00 AM ET
▼ -0.04 (-1.11%)

This chart shows the closing price for TNON by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tenon Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TNON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TNON

Analyst Price Target is $3.00
▼ -15.73% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Tenon Medical in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a -15.73% upside from the last price of $3.56.

This chart shows the closing price for TNON for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Tenon Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/20/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/18/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/16/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/14/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/12/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/12/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/14/2024BenchmarkReiterated RatingSpeculative Buy ➝ Speculative Buy$3.00 ➝ $3.00
4/15/2024BenchmarkLower TargetSpeculative Buy ➝ Speculative Buy$5.00 ➝ $3.00
3/10/2023BenchmarkReiterated RatingBuy$6.00
6/21/2022BenchmarkInitiated CoverageSpeculative Buy$6.00
(Data available from 10/12/2019 forward)

News Sentiment Rating

0.12 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/16/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/15/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/15/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/13/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/12/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/12/2024

Current Sentiment

  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Tenon Medical logo
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Read More

Today's Range

Now: $3.56
Low: $3.35
High: $3.92

50 Day Range

MA: $2.61
Low: $0.44
High: $7.71

52 Week Range

Now: $3.56
Low: $2.80
High: $37.60

Volume

304,281 shs

Average Volume

626,159 shs

Market Capitalization

$13.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenon Medical?

The following sell-side analysts have issued research reports on Tenon Medical in the last year: Benchmark Co..
View the latest analyst ratings for TNON.

What is the current price target for Tenon Medical?

1 Wall Street analysts have set twelve-month price targets for Tenon Medical in the last year. Their average twelve-month price target is $3.00, suggesting a possible downside of 15.7%. Benchmark Co. has the highest price target set, predicting TNON will reach $3.00 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $3.00 for Tenon Medical in the next year.
View the latest price targets for TNON.

What is the current consensus analyst rating for Tenon Medical?

Tenon Medical currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TNON will outperform the market and that investors should add to their positions of Tenon Medical.
View the latest ratings for TNON.

What other companies compete with Tenon Medical?

Other companies that are similar to Tenon Medical include NeuroMetrix, Check-Cap, Vivos Therapeutics, Plus Therapeutics and Nexalin Technology. Learn More about companies similar to Tenon Medical.

How do I contact Tenon Medical's investor relations team?

The company's listed phone number is 408-649-5760 and its investor relations email address is [email protected]@mzgroup.us. The official website for Tenon Medical is www.tenonmed.com. Learn More about contacing Tenon Medical investor relations.